Stay updated with breaking news from Sameh Elfangary. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AstraZeneca, a science-led biopharmaceutical and one of the top 10 biopharma companies globally, has signed a strategic partnership agreement with G42 Healthcare, an AI-powered healthcare company, to locally manufacture innovative drugs in Abu Dhabi.
Abu Dhabi received the first global shipment of AstraZeneca’s Evusheld, after gaining Emergency Use Authorization from the UAE’s Ministry of Health and Prevention.
G42 Healthcare, an Abu Dhabi-based leading health tech company, and AstraZeneca, a global, science-led biopharmaceutical firm, will collaborate to further enhance clinical research and diagnostics frameworks in the UAE.
G42 Healthcare, an Abu Dhabi-based leading health tech company, and AstraZeneca, a global, science-led biopharmaceutical firm, will collaborate to further enhance clinical research and diagnostics frameworks in the UAE.
The medication will be stored at Rafed’s Distribution Centre and then distributed to various destinations.